SCHEMBL6742236

SCHEMBL6742236

Cc1ccc(S(=O)(=O)OC(C)C2(c3ccccc3)OCCO2)cc1

nearest known ligand 0.37

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
VDR P11473 1/20 0.37
CYP2C19 P33261 1/20 0.36
HTT P42858 1/20 0.36
SMN1; SMN2 Q16637 1/20 0.36
ALDH1A1 P00352 4/20 0.36
MEN1 O00255 3/20 0.35
KMT2A Q03164 3/20 0.35
CA1 P00915 2/20 0.35
CA2 P00918 2/20 0.35
CA7 P43166 1/20 0.35
GAA P10253 1/20 0.35
KDM4E B2RXH2 1/20 0.35
MAPT P10636 1/20 0.35
TDP1 Q9NUW8 1/20 0.35
KEAP1 Q14145 1/20 0.35
NFE2L2 Q16236 1/20 0.35
DHODH Q02127 1/20 0.34
CA12 O43570 1/20 0.34
CA9 Q16790 1/20 0.34
NTSR2 O95665 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14132068 0.85 TDP1 (0.34) ALDH1A1TDP1
SCHEMBL14131948 0.84 MEN1 (0.36) HTTALDH1A1MEN1KMT2AKDM4E
SCHEMBL9339658 0.80 ALDH1A1 (0.33) SMN1; SMN2ALDH1A1MEN1KMT2AKDM4E
SCHEMBL11215964 0.79 KDM4E (0.40) HTTSMN1; SMN2ALDH1A1MEN1KMT2A
SCHEMBL11218055 0.75 L3MBTL1 (0.41) HTTSMN1; SMN2ALDH1A1MEN1KMT2A
SCHEMBL10817924 0.75 ALDH1A1 (0.37) CYP2C19HTTSMN1; SMN2ALDH1A1MEN1
SCHEMBL10880135 0.73 VDR (0.38) VDRCYP2C19HTTSMN1; SMN2ALDH1A1
SCHEMBL384387 0.71 CA12 (0.38) VDRCYP2C19HTTSMN1; SMN2ALDH1A1
SCHEMBL11988007 0.69 VDR (0.45) VDRCYP2C19HTTSMN1; SMN2ALDH1A1
SCHEMBL491994 0.69 VDR (0.45) VDRCYP2C19HTTSMN1; SMN2ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6692893-B2 ONIUM SALTS OF ARYLSULFONYLOXYNAPHTHALENESULFONATE ANIONS WITH IODONIUM OR SULFONIUM CATIONS; USE IN DEEP ULTRAVIOLET LITHOGRAPHY SHIN-ETSU CHEMICAL CO., LTD. (JP) 2004-02-17 US disclosed
US-20020076643-A1 Novel onium salts, photoacid generators, resist compositions, and patterning process SHIN-ETSU CHEMICAL CO., LTD. (JP) 2002-06-20 US disclosed
US-20020077493-A1 Novel onium salts, photoacid generators, resist compositions, and patterning process SHIN-ETSU CHEMICAL CO., LTD. (JP) 2002-06-20 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20020077493-A1 Novel onium salts, photoacid generators, resist compositions, and patterning process ABL1, PI4K2B, FES VDR 3664/4885CYP2C19 2373/4885HTT 3146/4885
US-20020076643-A1 Novel onium salts, photoacid generators, resist compositions, and patterning process PNN, PI4K2B, PI4K2A VDR 3576/4885CYP2C19 1943/4885HTT 2485/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.